Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 43.68M P/E - EPS this Y - Ern Qtrly Grth -
Income -83.41M Forward P/E -1.32 EPS next Y - 50D Avg Chg 15.00%
Sales 2.56M PEG - EPS past 5Y - 200D Avg Chg -32.00%
Dividend N/A Price/Book 0.39 EPS next 5Y - 52W High Chg -89.00%
Recommedations 2.00 Quick Ratio 4.24 Shares Outstanding 44.55M 52W Low Chg 68.00%
Insider Own 22.40% ROA -26.83% Shares Float 27.66M Beta 3.01
Inst Own 25.07% ROE -85.91% Shares Shorted/Prior 223.18K/345.38K Price 0.99
Gross Margin - Profit Margin - Avg. Volume 70,845 Target Price 6.00
Oper. Margin -2,516.28% Earnings Date May 2 Volume 34,635 Change 5.81%
About Senti Biosciences, Inc.

Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma. It also develops SENTI-401, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer/CRC cells. In addition, the company develops Tumor-Associated Antigen and Protective Antigen Paired Discovery Platform to select and validate NOT GATE antigen candidates and identify tumor-associated antigens in cancer cells. The company has a strategic collaboration with Celest Therapeutics (Shanghai) Co. Ltd for the clinical development of SENTI-301A to treat solid tumors. Senti Biosciences, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Senti Biosciences, Inc. News
03/21/24 Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights
01/05/24 Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program
12/26/23 Senti Bio (SNTI) Rises as FDA Clears IND for Cancer Candidate
12/22/23 Why Is Blood Cancer Focused Senti Biosciences Stock Trading Higher Today?
12/22/23 Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
11/13/23 Senti Bio Announces Third Quarter 2023 Results and Pipeline Updates
11/06/23 Senti Bio Announces New Strategic Collaboration with Celest Therapeutics for Clinical Development of SENTI-301A in China
10/31/23 Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer Annual Meeting
09/27/23 Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer 2023 Meeting
09/26/23 Senti Bio to Participate in Upcoming Conferences
09/05/23 Senti Bio to Participate in Upcoming Investor Conferences
08/11/23 Senti Biosciences, Inc. (SNTI) Reports Q2 Loss, Misses Revenue Estimates
08/11/23 Senti Bio Announces Second Quarter 2023 Results and Pipeline Updates
08/10/23 Senti Bio Announces Closing of Transaction Leveraging its CMC Capabilities into a Cell and Gene Therapy Manufacturing Innovation Business Backed by Celadon Partners
06/05/23 Here's Why Senti Biosciences (NASDAQ:SNTI) Must Use Its Cash Wisely
05/20/23 Senti Bio Highlights Initial Gene Circuit Data From Collaborations at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
05/09/23 Senti Bio Announces First Quarter 2023 Results and Pipeline Updates
05/02/23 Senti Bio Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 2023 Annual Meeting
04/17/23 Senti Bio Highlights Preclinical Data from Multiple Gene Circuit Enabled Cell Therapy Programs at Annual AACR Meeting
SNTI Chatroom

User Image matec Posted - 3 days ago

$SNTI -8% with only 20000 stocks all day, pure short attack

User Image matec Posted - 6 days ago

$SNTI down 8% with only 24000 stocks all day, no comnent

User Image MB11111 Posted - 1 week ago

$SNTI no surprise on Q4 results. all as expected which is great. first dosing of both IND in Q2... GLTA

User Image Stock_Titan Posted - 1 week ago

$SNTI Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights https://www.stocktitan.net/news/SNTI/senti-bio-reports-fourth-quarter-and-full-year-2023-financial-yswvelnaba9a.html

User Image Ozium1627 Posted - 1 week ago

$SNTI let’s keep this one heading in the right direction!! 🆙

User Image sixfigures718 Posted - 1 week ago

$SNTI Looking good

User Image RollingDollar Posted - 1 week ago

$SNTI

User Image MB11111 Posted - 1 week ago

$SNTI volume and price slowing crawling up…

User Image RollingDollar Posted - 1 week ago

$SNTI

User Image matec Posted - 1 week ago

$snti patent? +15%

User Image andreatorchio1970 Posted - 1 week ago

$SNTI

User Image Aainvest1 Posted - 1 week ago

$SNTI

User Image MB11111 Posted - 3 weeks ago

$SNTI wake me up when something finally happens

User Image matec Posted - 3 weeks ago

$SNTI very low volume shorters wins

User Image MB11111 Posted - 02/29/24

$SNTI https://www.linkedin.com/posts/senti-biosciences_healthcare-synbio-celltherapy-activity-7165805009442439168-aWeZ?utm_source=share&utm_medium=member_ios Coincidentally it bounced back after that…news coming IMHO!

User Image matec Posted - 1 month ago

$SNTI started?

User Image MB11111 Posted - 1 month ago

$SNTI something’s brewing?

User Image matec Posted - 1 month ago

$SNTI gene therapies using its proprietary Gene Circuit platform, announced plans to streamline its business operations, including reducing its workforce by approximately 37 percent, to enable increased focus on SENTI-202, a first-in-class Logic Gated investigational cell therapy for the treatment of acute myeloid leukemia

User Image Bloo334 Posted - 1 month ago

$SNTI anything supposed to happen next month?

User Image Spaghettisound1 Posted - 1 month ago

$SNTI https://seekingalpha.com/article/4671810-soundhound-ai-harmonizing-the-voice-ai-revolution-yet-awaiting-a-clearer-frequency

User Image matec Posted - 1 month ago

$SNTI an idiot place an order of 2000 for put down the stock

User Image BioTechChap Posted - 1 month ago

$SNTI Who profited from the bargain this morning?

User Image MB11111 Posted - 1 month ago

$SNTI deadly quiet in here…we should hear some news from China soon I believe

User Image Mandi63 Posted - 1 month ago

$TTOO $TPST $VVOS $BTTX $SNTI

User Image NEWBIGTECH Posted - 1 month ago

$SNTI Senti Biosciences presently has a consensus price target of $4.00, suggesting a potential upside of 856.48%. Given Senti Biosciences’ higher possible upside, analysts clearly believe Senti Biosciences is more favorable than $ZIVO Bioscience. 27.5% of Senti Biosciences shares are held by institutional investors. Comparatively, 14.1% of ZIVO Bioscience shares are held by institutional investors. 12.5% of Senti Biosciences shares are held by insiders. https://zolmax.com/investing/head-to-head-review-senti-biosciences-nasdaqsnti-versus-zivo-bioscience-nasdaqzivo/10108011.html

User Image Aainvest1 Posted - 1 month ago

$SNTI omggggg

User Image MB11111 Posted - 1 month ago

$SNTI no news is good news

User Image matec Posted - 1 month ago

$SNTI started big gain coming

User Image matec Posted - 1 month ago

$SNTI 0,65 $ coming

User Image NEWBIGTECH Posted - 1 month ago

$OPK $SNTI $ICU

Analyst Ratings
Chardan Capital Buy Aug 15, 23
Chardan Capital Buy May 11, 23
Morgan Stanley Equal-Weight Mar 24, 23
Chardan Capital Buy Mar 23, 23
Chardan Capital Buy Jan 30, 23
Morgan Stanley Equal-Weight Jan 27, 23
JP Morgan Neutral Dec 16, 22
Morgan Stanley Equal-Weight Oct 7, 22
B of A Securities Buy Sep 29, 22